BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Munich Startup - ECPv5.5.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Munich Startup
X-ORIGINAL-URL:https://cms.munich-startup.net
X-WR-CALDESC:Veranstaltungen für Munich Startup
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200514T160000
DTEND;TZID=Europe/Berlin:20200514T170000
DTSTAMP:20260429T022110
CREATED:20200422T090149Z
LAST-MODIFIED:20211026T072927Z
UID:59754-1589472000-1589475600@cms.munich-startup.net
SUMMARY:Online: A Healthcare Corporate VC Perspective on COVID-19
DESCRIPTION:The current health and economic crisis will impact corporate VC’s investment strategies over the coming months. \nFor healthcare and life science CVCs\, the accelerated development\, regulatory approval\, and adoption of new screening tools\, diagnostics\, and treatments will create a wealth of opportunities. \nDuring the session\, we will hear from experienced investors in this field about their perspectives on the current market dynamics and how these may eventually shape their own investment decisions. \nModerator:\nMarc Filerman\, CEO\, German Accelertor Life Sciences \nSpeakers:\nRohan Ganesh\, Principal\, Venture Capital\, Verily Life Sciences\nJoey Mason\, Head of Life Sciences Fund\, M Ventures \n 
URL:https://cms.munich-startup.net/veranstaltung/online-a-healthcare-corporate-vc-perspective-on-covid-19/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://cms.munich-startup.net/wp-content/uploads/2020/04/2020_05_14_Webinar_How-Healthcare-Investors-are-Adjusting-to-COVID-19_Visuals_Eventbrite.jpg
END:VEVENT
END:VCALENDAR